NOS1AP and schizophrenia: Such treatments will likely not adhere to diagnostic boundaries such as ‘schizophrenia’ or ‘depression’, but target defined neuropsychological deficits (here, compromised working memory and social interaction) in conjunction with evidence for abnormalities in NOS1AP interactions, in the sense of precision medicine approaches.